These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25092728)

  • 1. T-cell therapy for cervical cancer.
    Cancer Discov; 2014 Aug; 4(8):862. PubMed ID: 25092728
    [No Abstract]   [Full Text] [Related]  

  • 2. CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7.
    Höhn H; Pilch H; Günzel S; Neukirch C; Hilmes C; Kaufmann A; Seliger B; Maeurer MJ
    J Immunol; 1999 Nov; 163(10):5715-22. PubMed ID: 10553103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for gynaecological malignancies.
    Coukos G; Conejo-Garcia JR; Roden RB; Wu TC
    Expert Opin Biol Ther; 2005 Sep; 5(9):1193-210. PubMed ID: 16120050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
    Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
    Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer.
    de Vos van Steenwijk PJ; Heusinkveld M; Ramwadhdoebe TH; Löwik MJ; van der Hulst JM; Goedemans R; Piersma SJ; Kenter GG; van der Burg SH
    Cancer Res; 2010 Apr; 70(7):2707-17. PubMed ID: 20233872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel role of metalloproteinase in cancer-mediated immunosuppression.
    Sheu BC; Hsu SM; Ho HN; Lien HC; Huang SC; Lin RH
    Cancer Res; 2001 Jan; 61(1):237-42. PubMed ID: 11196168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
    Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
    J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunobiology of HPV Infection.
    Garcia-Chacon R; Velasco-Ramirez SF; Flores-Romo L; Daneri-Navarro A
    Arch Med Res; 2009 Aug; 40(6):443-8. PubMed ID: 19853184
    [No Abstract]   [Full Text] [Related]  

  • 11. [Papillomavirus infections and cervical tumorigenesis].
    Kiyono T
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):227-31. PubMed ID: 20235389
    [No Abstract]   [Full Text] [Related]  

  • 12. Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.
    Zehbe I; Kaufmann AM; Schmidt M; Hohn H; Maeurer MJ
    J Immunother; 2007; 30(5):523-32. PubMed ID: 17589293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
    Hilders CG; Houbiers JG; van Ravenswaay Claasen HH; Veldhuizen RW; Fleuren GJ
    Lab Invest; 1993 Dec; 69(6):651-9. PubMed ID: 8264228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer.
    Nakano T; Oka K; Hanba K; Morita S
    Clin Immunol Immunopathol; 1996 Apr; 79(1):79-86. PubMed ID: 8612354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the TIL and NK of IL-2 injected via pelvic retroperitoneal space in gynecological cancer patient].
    Chen J; Cao ZY; Zhang P; Peng ZL; Yang YL; Bi JH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):406-8. PubMed ID: 15181850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of the cervix: prospects for immunological control.
    Davies DH; McIndoe GA; Chain BM
    Int J Exp Pathol; 1991 Apr; 72(2):239-51. PubMed ID: 1849733
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor activity of Langerhans cells in radiation therapy for cervical cancer and its modulation with SPG administration.
    Nakano T; Oka K; Sugita T; Tsunemoto H
    In Vivo; 1993; 7(3):257-63. PubMed ID: 8357967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.
    Pilch H; Hoehn H; Schmidt M; Steiner E; Tanner B; Seufert R; Maeurer M
    Zentralbl Gynakol; 2002; 124(8-9):406-12. PubMed ID: 12655469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of human papillomavirus vaccines in cervical neoplasia.
    Stern PL; Faulkner R; Veranes EC; Davidson EJ
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell epitopes in human papilloma virus proteins.
    Sadovnikova E; Stauss HJ
    Behring Inst Mitt; 1994 Jul; (94):87-93. PubMed ID: 7528003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.